Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial
T Tsujino, Y Komatsu, H Isayama, K Hirano… - Clinical …, 2005 - Elsevier
Background & Aims: Pancreatitis remains the major complication of endoscopic retrograde
cholangiopancreatography (ERCP), and hyperenzymemia after ERCP is common. Because …
cholangiopancreatography (ERCP), and hyperenzymemia after ERCP is common. Because …
Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: A randomized, controlled trial
T Tsujino, Y Komatsu, H Isayama, K Hirano… - Clinical …, 2005 - infona.pl
Background & Aims: Pancreatitis remains the major complication of endoscopic retrograde
cholangiopancreatography (ERCP), and hyperenzymemia after ERCP is common. Because …
cholangiopancreatography (ERCP), and hyperenzymemia after ERCP is common. Because …
Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial
T Tsujino, Y Komatsu, H Isayama… - … : the official clinical …, 2005 - pubmed.ncbi.nlm.nih.gov
Background & aims Pancreatitis remains the major complication of endoscopic retrograde
cholangiopancreatography (ERCP), and hyperenzymemia after ERCP is common. Because …
cholangiopancreatography (ERCP), and hyperenzymemia after ERCP is common. Because …
[引用][C] Ulinastatine for pancreatitis after endoecopic retrograde cholangiopancreatography: a randomized, controlled trial
T TSUJINO - Clin Gastroenterol Hepatol, 2005 - cir.nii.ac.jp
Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: A randomized, controlled trial
T Tsujino, Y Komatsu, H Isayama, K Hirano… - Clinical …, 2005 - cghjournal.org
Background & Aims: Pancreatitis remains the major complication of endoscopic retrograde
cholangiopancreatography (ERCP), and hyperenzymemia after ERCP is common. Because …
cholangiopancreatography (ERCP), and hyperenzymemia after ERCP is common. Because …
Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial.
T Tsujino, Y Komatsu, H Isayama, K Hirano… - … and Hepatology: the …, 2005 - europepmc.org
Methods In a multicenter, randomized, double-blind, placebo-controlled trial, patients
undergoing a first ERCP were randomized to receive ulinastatin (150,000 U) or placebo by …
undergoing a first ERCP were randomized to receive ulinastatin (150,000 U) or placebo by …
[引用][C] Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: A randomized, controlled trial
T TSUJINO - Clin. Gastroenterol. Hepatol., 2005 - cir.nii.ac.jp